Food and Drug Administration
February 19, 2004
Slides
Options for Influenza Virus Vaccine Composition 2004-2005, Dr. Roland Levandowski, MD (HTM) (PPT)
Preparation of Reference Influenza Viruses in Mammalian Cells: FDA Perspective, Dr. Zhiping Ye, MD, PhD (HTM) (PPT)